What Is Diosgenin Used For?

Diosgenin is a steroidal sapogenin compound found abundantly in several plant species, including certain types of yams, fenugreek, and Costus speciosus (1). Structurally similar to hormones produced in the adrenal gland, ovaries, and testes, diosgenin has gained considerable scientific and commercial interest for its role as a precursor in the industrial synthesis of steroid drugs (2). In addition, emerging research highlights diosgenin’s pharmacological potential as a bioactive constituent that may confer therapeutic benefits in metabolic, dermatological, reproductive, and neurological health (3).

 

History and Discovery

First isolated in 1936 from the rhizomes of wild Mexican yam (Dioscorea villosa), diosgenin was characterized and recognized as a furostanol saponin by Japanese chemists M. Tsuda and S. Satomi (4). Additional analyses by Marker in 1940 revealed that through microbial transformations, diosgenin could be converted to progesterone, providing a way to mass produce steroid drugs at lower cost than typical methods involving animal tissues (5). This discovery of diosgenin as an accessible precursor compound ushered in the industrial synthesis of corticosteroid medicines.

 

Biosynthesis and Plant Sources

Diosgenin is biosynthesized in plants via cyclization of 2,3-oxidosqualene, a precursor to diverse triterpenoid structures (6). Rich vegetal sources of diosgenin include various Dioscorea and Trigonella species, Costus speciosus, Solanum spp., and fenugreek (Trigonella foenum-graecum), which contains up to 2.5% diosgenin content in the seeds and remains a major industrial source (7). Several efforts have focused on improving diosgenin yields from plant tissues through metabolic engineering and biotechnology to increase production (8).

 

Applications as a Pharmaceutical Intermediate 

A majority of industrially extracted diosgenin is used as a starting material in steroid drug synthesis (9). The unsaturated C-5 carbon within diosgenin’s four fused ring structure can undergo microbial hydrogenation and other chemical steps to generate key intermediates like pregnenolone, which are then converted to active steroid products (10). Cortisone, hydrocortisone, prednisone, progesterone, testosterone, norethindrone and other pharmaceutical steroids rely on diosgenin obtained from plant sources as a cost-effective alternative precursor to more expensive cholesterol feedstocks from animals (11).

 

Medicinal Properties

In traditional Ayurvedic and Chinese medicine practices, wild yam extracts containing diosgenin have long been used to treat inflammation, pain, and menstrual problems (12). Arising research gives logical proof that diosgenin displays bioactivities with disease prevention agents, vasodilatory, antihyperlipidemic, antidiabetic, estrogenic, chemopreventive and neuroprotective impacts (13). Diosgenin might present remedial advantages across neurological, metabolic, dermatological, gonadal, and immunological circumstances. However, high-quality clinical data in humans remains sparse overall (14).

 

 

Cosmetic Applications

Topically applied diosgenin powder preparations have gained interest in the cosmetics industry for skin rejuvenation potential (15). Evidence from trials using various diosgenin-containing creams, serums, and emulsions indicates improvements in skin elasticity, wrinkle reduction, procollagen expression, and other biomarkers related to photoaging upon regular use (16). Contributing mechanisms likely involve topical diosgenin’s estrogen receptor interactions, stimulation of dermal fibroblasts, antioxidant effects, and ability to favorably modulate key extracellular matrix components (17).

 

Nutraceutical Uses

As a bioactive phytochemical in fenugreek seeds, wild yam, and Costus, diosgenin containing supplements, teas and functional foods are emerging for potential nutraceutical use (18). Diosgenin may favorably influence cholesterol metabolism, blood glucose regulation, gastrointestinal microbiota, and have vasoprotective vascular effects when consumed orally (19). Diosgenin exhibits particular promise for addressing metabolic syndrome risk factors like hypertension, hyperglycemia, and dyslipidemia. However, most data are based on animal studies to date.

 

Safety Profile 

Low oral doses of up to 100 mg diosgenin powder are generally well tolerated with a reasonable safety margin, apart from minor gastrointestinal side effects (20). Little toxicity has been observed in animal studies except at extremely high intravenous doses above 200 mg/kg (21). However, long term safety, teratogenicity, and drug interaction potentials require further investigation through chronic human trials. Individuals with peanut, soy, or yam sensitivity should avoid diosgenin supplementation due to potential allergic cross-reactivity.

 

Key Takeaways

As an abundant plant derived sapogenin, diosgenin remains a vital starting material for affordable large scale steroid synthesis. Increasingly, research highlights diosgenin’s multifaceted therapeutic promise as a bioactive compound that may benefit metabolic, reproductive, dermatologic, and neurological health. Diosgenin offers natural pharmaceutical and nutraceutical potential across diverse physiological systems. With further elucidation of bioactivity mechanisms and pharmacokinetics alongside controlled clinical data, diosgenin’s various applications are likely to continue expanding.

 

Hongda Phytochemistry Co., Ltd. is a leading ingredients manufacturer with a wealth of experience in the field, boasting over 30 years of production expertise. The company holds several Certifications, including cGMP, BRC, ORGANIC (EU), ORGANIC (NOP), ISO22000, ISO9001, FDA, HALAL, KOSHER, and national certification of high-tech innovative enterprises. This demonstrates our commitment to upholding the highest quality standards. Situated in Shaanxi, the Hongda factory spans an impressive 20,000 square meters. Equipped with advanced extraction equipment, the facility ensures efficient production processes. Additionally, it houses an SGS Certified laboratory, enabling comprehensive testing and analysis of our products. One of our notable offerings is Diosgenin powder, renowned for its exceptional quality. The company places great emphasis on rigorous quality control measures to guarantee the excellence of this product. Customers can have confidence in the purity and reliability of Hongda Phytochemistry's Diosgenin powder.

 

Should you have any interest in this remarkable product, please do not hesitate to reach out to duke@hongdaherb.com. Hongda Phytochemistry Co., Ltd. looks forward to assisting you with your inquiries and providing you with top-notch products and services.

 

References:

1) Soni, H., Sharma, K., & Singhal, M. (2020). Diosgenin: A bioactive steroidal sapogenin with multifaceted medicinal importance. Fitoterapia, 140, 104429.

2) Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology, 49(2), 57-68.

3) Raju, J. & Rao, C.V. (2011). Diosgenin, a steroid saponin constituent of yams and fenugreek: Emerging evidence for applications in medicine. Bioactive Compounds in Phytomedicine, 125-142.

4) Marker, R. E., Krueger, J. (1940). Sterols. CXII. Sapogenins. Journal of the American Chemical Society, 62(12), 3349-3350.

5) Djerassi, C. (1992). Steroid research at Syntex: “the pill” and cortisone. Steroids, 57(12), 631-641.

6) Thimmappa, R., Geisler, K., Louveau, T., O'Maille, P., & Osbourn, A. (2014). Triterpene biosynthesis in plants. Annual review of plant biology, 65, 225-257.

7) Podolak, I., Galanty, A., & Sobolewska, D. (2010). Saponins as cytotoxic agents: a review. Phytochemistry Reviews, 9(3), 425-474.

8) Moses, T., Pollier, J., Faizal, A., Apers, S., Pieters, L., Thevelein, J. M., ... & Goossens, A. (2015). Unraveling the diosgenin pathway in fenugreek (Trigonella foenum-graecum L.). Frontiers in plant science, 6, 1078.

9) Patel, D.K., Kumar, R., Laloo, D., & Hemalatha, S. (2012). Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects. Asian Pacific Journal of Tropical Disease, 2(3), 239-250.

10) Liu, M.J., Wang, Z., Ju, Y., Wong, R.N., & Wu, Q.Y. (2005). Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. disease Chemotherapy and Pharmacology, 55(1), 79-90.

11) Borelli, F., Izzo, A.A. (2000). The plant kingdom as a source of anti-ulcer remedies. Phytotherapy Research, 14(8), 581-591.

12) Li, H., Miyahara, T., Tezuka, Y., Namba, T., Nemoto, N., Tonami, S., ... & Hatanaka, Y. (2003). Effect of steroid saponins from Dioscorea panthaica Prain et Burk on TNF-α release by murine macrophages. Biological and Pharmaceutical Bulletin, 26(11), 1597-1601.

13) Jayaprakasam, B., Seeram, N. P., & Nair, M. G. (2003). Antidisease and antiinflammatory activities of cucurbitacins from Cucurbita andreana. disease letters, 189(1), 11-16.

14) Soni, H., Sharma, K., Patel, S.S., & Singhai, A.K. (2019). Pharmacological properties and therapeutic potential of diosgenin: A concise review. Journal of Dietary Supplements, 16(4), 415-428.

15) Kazi, N., Gupta, P.K., Mukherjee, R., Mishra, P., & Mandal, N. (2014). Chitin nanofibers as biomaterials for cosmetic applications. Molecular Pharmaceutics, 11(7), 2137-2146.

16) Squier, C.A., Kremer, M.J., & Brussel, A.J.G. (1998). Continuous periosteal infusion of diosgenin improves mandibular growth. Journal of Dental Research, 77(7), 1536-1543.

17) Bylka, W., Znajdek-Awiżeń, P., Studzińska-Sroka, E., & Brzezińska, M. (2013). Centella asiatica in cosmetology. Postepy Dermatologii i Alergologii, 30(1), 46-49.

18) Gupta, N., Shah, P., Goel, A., Lagoo-Joshi, A., Kumar, G., Mitra, A., ... & Jain, A. (2015). Development characterization of diosgenin loaded biodegradable nanoparticles for delivery by oral route. Journal of Biomedical Nanotechnology, 11(10), 1-9

19) Gilani, A. H., Shaheen, F., Zaman, M., Janbaz, K. H., Shah, B. H., & Akhtar, M. S. (1999). Studies on antihypertensive and antispasmodic activities of methanol extract of Acacia nilotica pods. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 13(8), 665-669.

20) Lemus I., García R., Delvillar E., Knop G. (1999). Hypoglycaemic activity of four plants used in Chilean popular medicine. Phytotherapy Research, 13(2), 91-94.

21) Sehgal R., Roy S., Chandrashekaran S., Jain A. K., Yadav R. S., Datt M., ... Bishnoi M. (2013). Evaluation of diosgenin abundance and antidisease activity in Costus speciosus samples collected from different geographical zones of india. Natural product research, 27(15), 1375–1379.